{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:26:01Z","timestamp":1790371561418,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.tracli.2020.06.008","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T11:42:22Z","timestamp":1594381342000},"page":"115-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Effects of ABO incompatibility in allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1016","volume":"27","author":[{"given":"P.","family":"Ataca Atilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Akkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Atilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Gokmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Civriz Bozdag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kocak Toprak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kurt Yuksel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ozcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Demirer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Ilhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Beksac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Akan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Topcuoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Gurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2020.06.008_bib0150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.bmt.1703135","article-title":"Hematopoietic stem cell transplantation between red cell incompatible donor-recipient pairs","volume":"28","author":"Rowley","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.tracli.2020.06.008_bib0155","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3324\/haematol.2008.001057","article-title":"AB0-incompatible allogeneic hematopoietic stem cell transplantation","volume":"93","author":"Worel","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.tracli.2020.06.008_bib0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000441507","article-title":"ABO-mismatched allogeneic hematopoietic stem cell transplantation","volume":"43","author":"Worel","year":"2016","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.tracli.2020.06.008_bib0165","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1182\/blood.V75.1.290.290","article-title":"Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation","volume":"75","author":"Gmur","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2020.06.008_bib0170","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.bbmt.2016.07.019","article-title":"Impact of graft-recipient ABO compatibility on outcomes after umbilical cord blood transplant for nonmalignant disease","volume":"22","author":"Kudek","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.tracli.2020.06.008_bib0175","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbmt.2013.11.011","article-title":"Analysis of donor and recipient ABO incompatibility and antibody-associated complications after allogeneic stem cell transplantation with reduced-intensity conditioning","volume":"20","author":"Watz","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.tracli.2020.06.008_bib0180","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.bbmt.2010.03.021","article-title":"Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source","volume":"16","author":"Blin","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.tracli.2020.06.008_bib0185","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.bbmt.2014.12.036","article-title":"ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation","volume":"21","author":"Logan","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.tracli.2020.06.008_bib0190","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4161\/oxim.2.2.8355","article-title":"Specific factors influence success of autologous and allogeneic hematopoietic stem cell transplantation","volume":"2","author":"Goncalves","year":"2009","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.tracli.2020.06.008_bib0195","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bbmt.2018.09.014","article-title":"Characterization of late acute and chronic graft-versus-host disease according to the 2014 National Institutes of health consensus criteria in Japanese patients","volume":"25","author":"Ito","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.tracli.2020.06.008_bib0200","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.transci.2018.04.017","article-title":"Transfusion policy in allogeneic hematopoietic stem cell transplantation","volume":"57","author":"Topcuoglu","year":"2018","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2020.06.008_bib0205","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3324\/haematol.2016.160804","article-title":"Impact of ABO incompatibility on patients\u2019outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia-a report from the Acute Leukemia Working Party of the EBMT","volume":"102","author":"Canaani","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.tracli.2020.06.008_bib0210","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.bbmt.2005.07.015","article-title":"ABO blood group barrier in allogeneic bone marrow transplantation revisited","volume":"11","author":"Seebach","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.tracli.2020.06.008_bib0215","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/pbc.21025","article-title":"ABO Incompatible Stem Cell Transplantation in children does not influence outcome","volume":"49","author":"Helming","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.tracli.2020.06.008_bib0220","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.3324\/haematol.12933","article-title":"Japan marrow donor program. Impact of ABO Blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan marrow donor program","volume":"93","author":"Kimura","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.tracli.2020.06.008_bib0225","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1182\/blood.V98.7.2043","article-title":"Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age","volume":"98","author":"Kollman","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2020.06.008_bib0230","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/ctr.12840","article-title":"ABO blood group antigen mismatch has an impact on outcome after allogeneic peripheral blood stem cell transplantation","volume":"30","author":"Grube","year":"2016","journal-title":"Clin Transplant"},{"key":"10.1016\/j.tracli.2020.06.008_bib0235","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1046\/j.1537-2995.2000.40050543.x","article-title":"Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems","volume":"40","author":"Worel","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2020.06.008_bib0240","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood.V98.6.1687","article-title":"Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation","volume":"98","author":"Bolan","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2020.06.008_bib0245","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.bmt.1703621","article-title":"Consequences of ABOincompatibility in allogeneic hematopoietic stem cell transplantation","volume":"30","author":"Stussi","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.tracli.2020.06.008_bib0250","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/00007890-198806000-00018","article-title":"ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation","volume":"45","author":"Bacigalupo","year":"1988","journal-title":"Transplantation"},{"key":"10.1016\/j.tracli.2020.06.008_bib0255","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1053\/bbmt.2001.v7.pm11760150","article-title":"Analysis of risk factors for the development of GVHD after T celldepleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion","volume":"7","author":"Keever-Taylor","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.tracli.2020.06.008_bib0260","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/trf.12466","article-title":"Allogeneic peripheral blood stem cell transplantation using reduced-intensity conditioning in an outpatient setting in ABO-incompatible patients: are survival and graft-versus-host disease different?","volume":"54","author":"Gutierrez-Aguirre","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2020.06.008_bib0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.htct.2018.05.007","article-title":"Assessing the impact of ABO incompatibility on major allogeneic hematopoietic stem cell transplant outcomes: a prospective, single-center, cohort study","volume":"41","author":"Junior","year":"2019","journal-title":"Hematol Transfus Cell Ther"},{"key":"10.1016\/j.tracli.2020.06.008_bib0270","first-page":"150","article-title":"The processing of stem cell concentrates from the bone marrow in ABO-incompatible transplants:how and when","volume":"12","author":"Daniele","year":"2014","journal-title":"Blood Transfus"},{"key":"10.1016\/j.tracli.2020.06.008_bib0275","first-page":"4605","article-title":"Comparison of techniques for dealing with major abo-incompatible marrow transplants","volume":"19","author":"Bensinger","year":"1987","journal-title":"Transplant Proc"},{"key":"10.1016\/j.tracli.2020.06.008_bib0280","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jca.21470","article-title":"Guidelines on the use of thera-peutic apheresis in clinical practice-evidence-based approach from the writing Committee of the American Society for apheresis: the seventh special issue","volume":"31","author":"Padmanabhan","year":"2016","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tracli.2020.06.008_bib0285","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/152581699320207","article-title":"Bone marrow processing for transplantation using the COBE spectra cell separator","volume":"8","author":"Koristek","year":"1999","journal-title":"J Hematother Stem Cell Res"},{"key":"10.1016\/j.tracli.2020.06.008_bib0290","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1537-2995.2011.03069.x","article-title":"Approach ABO-incompatible Hematopoietic Pregenitor Cell Transplantation?","volume":"51","author":"Daniel-Johnson","year":"2011","journal-title":"Transfusion"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782020300835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782020300835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:38:25Z","timestamp":1761129505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782020300835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1246782020300835"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2020.06.008","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of ABO incompatibility in allogeneic hematopoietic stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2020.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 fran\u00e7aise de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}